<!DOCTYPE html><html lang="en"><head><meta charset="UTF-8"><meta name="viewport" content="width=device-width,initial-scale=1.0"><title>Diabetes Glossary — SugarWise</title><link rel="stylesheet" href="styles.css">
    <link rel="icon" type="image/svg+xml" href="favicon.svg"><link rel="manifest" href="manifest.json"><meta name="theme-color" content="#1a7a5a"><meta property="og:type" content="website"><meta property="og:site_name" content="SugarWise"><meta property="og:url" content="https://aravindcleaerr.github.io/diabetes-guide/diabetes-glossary.html"><meta property="og:description" content="Free educational diabetes management guide. Not medical advice."></head><body>
<a href="#main" class="skip-link">Skip to content</a>
<nav class="navbar"><div class="navbar-inner"><a class="brand" href="index.html">SugarWise</a><a class="home-link" href="index.html">All Topics</a></div></nav>
<div class="container" id="main" role="main">
<div class="page-header"><h1>Diabetes Glossary</h1><p>Key terms and definitions you will encounter on your diabetes journey</p></div>
<div class="last-reviewed">Content last reviewed: January 2026 | AI-assisted content</div>

<div class="illus">
<svg width="160" height="130" viewBox="0 0 160 130" xmlns="http://www.w3.org/2000/svg">
<style>.book{fill:#1a7a5a;animation:float 3s ease-in-out infinite}.book-page{fill:#f5f7fa}.book-line{stroke:#38a169;stroke-width:2;stroke-linecap:round;animation:fadeIn 1s ease-out both}</style>
<rect x="30" y="20" width="100" height="90" rx="4" class="book"/>
<rect x="35" y="18" width="90" height="90" rx="3" class="book-page"/>
<rect x="80" y="18" width="2" height="90" fill="#e2e8f0"/>
<line x1="42" y1="35" x2="72" y2="35" class="book-line"/>
<line x1="42" y1="45" x2="68" y2="45" class="book-line" style="animation-delay:0.2s"/>
<line x1="42" y1="55" x2="74" y2="55" class="book-line" style="animation-delay:0.4s"/>
<line x1="42" y1="65" x2="66" y2="65" class="book-line" style="animation-delay:0.6s"/>
<line x1="42" y1="75" x2="70" y2="75" class="book-line" style="animation-delay:0.8s"/>
<line x1="88" y1="35" x2="118" y2="35" class="book-line" style="animation-delay:0.1s"/>
<line x1="88" y1="45" x2="114" y2="45" class="book-line" style="animation-delay:0.3s"/>
<line x1="88" y1="55" x2="116" y2="55" class="book-line" style="animation-delay:0.5s"/>
<line x1="88" y1="65" x2="112" y2="65" class="book-line" style="animation-delay:0.7s"/>
<text x="52" y="122" font-size="11" font-weight="bold" fill="#145e45">A-Z</text>
</svg>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F520;</span> A–C</h2>
<table>
<tr><th>Term</th><th>Definition</th></tr>
<tr><td><strong>Autoimmune</strong></td><td>A condition in which the body's immune system mistakenly attacks its own cells. In Type 1 diabetes, the immune system destroys insulin-producing beta cells.</td></tr>
<tr><td><strong>Basal Insulin</strong></td><td>Long-acting or intermediate-acting insulin that provides a steady, low-level background supply of insulin throughout the day and night. Examples: Lantus (glargine), Tresiba (degludec), Levemir (detemir), NPH.</td></tr>
<tr><td><strong>Beta Cells</strong></td><td>Cells located in the islets of Langerhans in the pancreas that produce, store, and release insulin. Destruction of beta cells causes Type 1 diabetes; dysfunction causes Type 2.</td></tr>
<tr><td><strong>Blood Glucose</strong></td><td>The concentration of glucose (sugar) in the blood, measured in mg/dL (India, US) or mmol/L (UK). Normal fasting: 70–100 mg/dL.</td></tr>
<tr><td><strong>Bolus Insulin</strong></td><td>Rapid-acting or short-acting insulin taken before meals to cover the rise in blood glucose from food. Examples: NovoRapid (aspart), Humalog (lispro), Apidra (glulisine), regular insulin.</td></tr>
<tr><td><strong>CGM (Continuous Glucose Monitor)</strong></td><td>A wearable device with a tiny sensor inserted under the skin that measures glucose levels in interstitial fluid every 1–5 minutes and displays trends. Examples: FreeStyle Libre, Dexcom G6/G7, Medtronic Guardian.</td></tr>
<tr><td><strong>C-Peptide</strong></td><td>A protein released alongside insulin by the pancreas. Measuring C-peptide helps determine how much insulin the body is still producing. Low C-peptide suggests Type 1 or late-stage Type 2.</td></tr>
<tr><td><strong>Carb Counting</strong></td><td>A meal-planning method where you count the grams of carbohydrate in each meal to match insulin doses accurately.</td></tr>
</table>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F524;</span> D–G</h2>
<table>
<tr><th>Term</th><th>Definition</th></tr>
<tr><td><strong>DKA (Diabetic Ketoacidosis)</strong></td><td>A life-threatening emergency caused by severe insulin deficiency, leading to very high blood sugar, ketone production, and blood acidification. Most common in Type 1 but can occur in Type 2. Symptoms: nausea, vomiting, abdominal pain, fruity breath, rapid breathing. Requires immediate hospitalisation.</td></tr>
<tr><td><strong>Dawn Phenomenon</strong></td><td>A natural rise in blood glucose in the early morning hours (4–8 AM) caused by hormonal changes (cortisol, growth hormone). Common in both Type 1 and Type 2.</td></tr>
<tr><td><strong>eGFR (Estimated Glomerular Filtration Rate)</strong></td><td>A blood test measuring kidney function. Normal: &gt; 90 mL/min. Below 60 indicates chronic kidney disease. Calculated from serum creatinine, age, sex, and race.</td></tr>
<tr><td><strong>Fasting Glucose</strong></td><td>Blood glucose level measured after at least 8 hours of not eating. Normal: 70–100 mg/dL. Prediabetes: 100–125 mg/dL. Diabetes: 126 mg/dL or higher.</td></tr>
<tr><td><strong>GAD Antibodies (Glutamic Acid Decarboxylase)</strong></td><td>Antibodies that attack beta cells. A positive GAD antibody test helps confirm autoimmune diabetes (Type 1 or LADA).</td></tr>
<tr><td><strong>GLP-1 (Glucagon-Like Peptide 1)</strong></td><td>A gut hormone that stimulates insulin secretion, suppresses glucagon, slows gastric emptying, and promotes satiety. GLP-1 receptor agonist medications (e.g., liraglutide/Victoza, semaglutide/Ozempic) mimic this hormone.</td></tr>
<tr><td><strong>Glycaemic Index (GI)</strong></td><td>A scale from 0–100 ranking foods by how quickly they raise blood glucose. Low GI (&lt; 55): lentils, most vegetables, whole grains. High GI (&gt; 70): white rice, white bread, potatoes.</td></tr>
<tr><td><strong>Glucagon</strong></td><td>A hormone produced by alpha cells in the pancreas that raises blood glucose by stimulating the liver to release stored glucose. Used as an emergency injection/nasal spray for severe hypoglycaemia.</td></tr>
</table>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F521;</span> H–K</h2>
<table>
<tr><th>Term</th><th>Definition</th></tr>
<tr><td><strong>HbA1c (Glycated Haemoglobin)</strong></td><td>A blood test showing average blood glucose over the past 2–3 months. Expressed as a percentage. Normal: &lt; 5.7%. Prediabetes: 5.7–6.4%. Diabetes: &ge; 6.5%. Target for most diabetics: &lt; 7%.</td></tr>
<tr><td><strong>HHS (Hyperosmolar Hyperglycaemic State)</strong></td><td>A life-threatening emergency in Type 2 diabetes characterised by extremely high blood sugar (&gt; 600 mg/dL), severe dehydration, and altered consciousness, without significant ketosis. Requires immediate hospitalisation.</td></tr>
<tr><td><strong>Hyperglycaemia</strong></td><td>High blood glucose, generally defined as above 180 mg/dL (post-meal) or above 130 mg/dL (fasting). Chronic hyperglycaemia causes long-term diabetes complications.</td></tr>
<tr><td><strong>Hypoglycaemia</strong></td><td>Low blood glucose, generally below 70 mg/dL. Symptoms: shakiness, sweating, confusion, rapid heartbeat. Severe hypoglycaemia (below 54 mg/dL) can cause seizures or loss of consciousness. Treated with fast-acting glucose.</td></tr>
<tr><td><strong>Insulin</strong></td><td>A hormone produced by beta cells in the pancreas that allows glucose to enter cells for energy. People with Type 1 produce no insulin; people with Type 2 produce insufficient insulin or cannot use it effectively.</td></tr>
<tr><td><strong>Insulin Resistance</strong></td><td>A condition in which cells do not respond normally to insulin, requiring the pancreas to produce more to achieve the same effect. Central to the pathophysiology of Type 2 diabetes, prediabetes, and metabolic syndrome.</td></tr>
<tr><td><strong>Islets of Langerhans</strong></td><td>Clusters of cells in the pancreas containing alpha cells (glucagon), beta cells (insulin), delta cells (somatostatin), and other endocrine cells.</td></tr>
<tr><td><strong>Ketones</strong></td><td>Chemicals produced when the body breaks down fat for energy instead of glucose. Small amounts are normal during fasting; high levels (ketonuria/ketonaemia) in a diabetic indicate insulin deficiency and can lead to DKA.</td></tr>
</table>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F522;</span> L–O</h2>
<table>
<tr><th>Term</th><th>Definition</th></tr>
<tr><td><strong>LADA (Latent Autoimmune Diabetes in Adults)</strong></td><td>A slowly progressing form of autoimmune diabetes in adults (often misdiagnosed as Type 2). Positive for autoantibodies (GAD), but may not need insulin immediately. Sometimes called "Type 1.5."</td></tr>
<tr><td><strong>Lipodystrophy</strong></td><td>Abnormal fat tissue at injection sites — either lumps (lipohypertrophy) or indentations (lipoatrophy) — caused by repeated injections in the same area. Affects insulin absorption. Prevented by proper site rotation.</td></tr>
<tr><td><strong>Macrovascular Complications</strong></td><td>Diabetes complications affecting large blood vessels: coronary artery disease (heart attack), cerebrovascular disease (stroke), and peripheral arterial disease.</td></tr>
<tr><td><strong>Microvascular Complications</strong></td><td>Diabetes complications affecting small blood vessels: retinopathy (eyes), nephropathy (kidneys), and neuropathy (nerves).</td></tr>
<tr><td><strong>Nephropathy (Diabetic)</strong></td><td>Kidney damage caused by diabetes. Detected by elevated UACR (albumin in urine) and reduced eGFR. Can progress to end-stage kidney disease requiring dialysis or transplant if uncontrolled.</td></tr>
<tr><td><strong>Neuropathy (Diabetic)</strong></td><td>Nerve damage caused by diabetes. Most common is peripheral neuropathy (tingling, numbness, pain in feet and hands). Autonomic neuropathy affects internal organs (heart, digestion, bladder).</td></tr>
<tr><td><strong>OGTT (Oral Glucose Tolerance Test)</strong></td><td>A diagnostic test: blood glucose is measured fasting and 2 hours after drinking 75 g of glucose. Used to diagnose diabetes and gestational diabetes. 2-hour value &ge; 200 mg/dL = diabetes.</td></tr>
</table>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F523;</span> P–S</h2>
<table>
<tr><th>Term</th><th>Definition</th></tr>
<tr><td><strong>Pancreas</strong></td><td>An organ behind the stomach that produces insulin and glucagon (endocrine function) and digestive enzymes (exocrine function).</td></tr>
<tr><td><strong>Peripheral Arterial Disease (PAD)</strong></td><td>Narrowing of arteries in the legs and feet due to atherosclerosis. Common in diabetics. Symptoms: leg pain on walking (claudication), poor wound healing, cold feet. Risk of amputation if severe.</td></tr>
<tr><td><strong>Postprandial</strong></td><td>After a meal. Postprandial blood glucose is typically measured 2 hours after starting a meal. Target: &lt; 180 mg/dL for most diabetics.</td></tr>
<tr><td><strong>Retinopathy (Diabetic)</strong></td><td>Damage to blood vessels in the retina caused by chronic hyperglycaemia. Leading cause of blindness in working-age adults. Stages: mild, moderate, severe non-proliferative; proliferative. Detected by dilated eye exam.</td></tr>
<tr><td><strong>SGLT2 Inhibitors</strong></td><td>A class of oral diabetes medications that work by blocking glucose reabsorption in the kidneys, causing excess glucose to be excreted in urine. Examples: dapagliflozin (Forxiga), empagliflozin (Jardiance), canagliflozin (Invokana). Also provide heart and kidney protection.</td></tr>
<tr><td><strong>Sulfonylurea</strong></td><td>A class of oral diabetes medications that stimulate the pancreas to produce more insulin. Examples: glimepiride, gliclazide, glipizide. Risk of hypoglycaemia and weight gain.</td></tr>
</table>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F51A;</span> T–Z</h2>
<table>
<tr><th>Term</th><th>Definition</th></tr>
<tr><td><strong>Time in Range (TIR)</strong></td><td>The percentage of time blood glucose stays within the target range (typically 70–180 mg/dL) over a given period. Measured by CGM. Target: &gt; 70%. Higher TIR correlates with lower complication risk.</td></tr>
<tr><td><strong>Type 1 Diabetes</strong></td><td>An autoimmune disease in which the immune system destroys beta cells, resulting in absolute insulin deficiency. Requires lifelong insulin therapy. Typically diagnosed in children and young adults but can occur at any age (including as LADA).</td></tr>
<tr><td><strong>Type 2 Diabetes</strong></td><td>A metabolic disease characterised by insulin resistance and progressive beta cell dysfunction. Accounts for ~90% of all diabetes cases. Managed with lifestyle changes, oral medications, and/or insulin. Strong genetic and lifestyle risk factors.</td></tr>
<tr><td><strong>UACR (Urine Albumin-to-Creatinine Ratio)</strong></td><td>A urine test for early kidney damage. Normal: &lt; 30 mg/g. Moderately increased albuminuria: 30–300 mg/g. Severely increased: &gt; 300 mg/g.</td></tr>
</table>
</div>

<div class="page-nav">
<a class="prev" href="inspiration-stories.html">Inspiration Stories</a>
<a class="next" href="resources.html">Resources</a>
</div>
</div>
<div class="disclaimer">This content is for educational purposes only and does not replace professional medical advice. The creators of SugarWise are not medical professionals. Do not start, stop, or change any medication without consulting your doctor. In case of emergency, call 112 (India) or your local emergency number. <a href="terms-of-use.html">Read full Terms of Use &amp; Medical Disclaimer</a></div>
<div class="privacy-notice">SugarWise does not use cookies, collect personal data, or track users.</div>
<div class="footer"><span class="ai-badge">AI-Assisted Content</span><br>SugarWise &bull; Comprehensive Diabetes Management Companion &bull; <a href="terms-of-use.html">Terms of Use</a> &bull; Last updated: January 2026</div>
<button class="theme-toggle" id="themeToggle" aria-label="Toggle dark mode" title="Toggle dark mode">&#9790;</button>
<button class="scroll-top" aria-label="Scroll to top" id="scrollTop" title="Back to top">&uarr;</button>
<script>
var sb=document.getElementById('scrollTop');window.addEventListener('scroll',function(){sb.classList.toggle('visible',window.scrollY>400)});sb.addEventListener('click',function(){window.scrollTo({top:0,behavior:'smooth'})});
</script>
<script>
if('serviceWorker' in navigator){navigator.serviceWorker.register('sw.js');}
(function(){var t=document.getElementById('themeToggle');var saved=localStorage.getItem('theme');if(saved){document.documentElement.setAttribute('data-theme',saved);t.textContent=saved==='dark'?'\u2600':'\u263E';}t.addEventListener('click',function(){var d=document.documentElement.getAttribute('data-theme')==='dark'?'':'dark';document.documentElement.setAttribute('data-theme',d);localStorage.setItem('theme',d);t.textContent=d==='dark'?'\u2600':'\u263E';});})();
</script></body></html>